The 250500 mcg subcutaneous range used in current research contexts sits below the 1 mg clinical trial dose, partly because subcutaneous bioavailability differs from the oral administration used in some trial arms
We summarize key mechanisms of action, categorize clinically relevant peptide classes, and address current limitations, including gaps in human data, safety considerations, and regulatory ambiguity
The hope is that this is done without a law change as this would be the fastest method
Available from: Brcic L, Brcic I, Staresinic M, Novinscak T, Sikiric P, Seiwerth S
B12 deficiency can only be diagnosed by your GP, as as well as assessing your clinical signs and symptoms they will also take a blood test to monitor the levels of B12 in your blood
It is composed of 15 amino acids in a very particular sequence that doesnt exist naturally